drugset / Trial / NCT01870635
Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan
Phase 4
Completed
625 enrolled
Dr. Stephen Freedman
Aga Khan University · collabBill and Melinda Gates Foundation · collabThrasher Research Fund · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective is to determine if the administration of a single dose of oral ondansetron (an anti-vomiting medication), compared to placebo, results in a reduction in intravenous (IV) rehydration therapy in children presenting for emergency department care with vomiting and diarrhea in Pakistan.
Timeline
- Start
- 2014-05
- Primary completion
- 2017-01-20
- Completion
- 2017-02-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 2 mg | Oral |
| Subject | Ondansetron | Other / unclassified | 4 mg | Oral |